Series A - Elixiron Immunotherapeutics
Investment Firm
Overview
Elixiron Immunotherapeutics is a company developing therapeutics for cancer, rare, and inflammatory disorders
Announced Date
Aug 23, 2021
Funding Type
Series A
Highlights
Location
Asia
Social
Participant Investors
3
Round Details and Background
Elixiron Immunotherapeutics raised an undisclosed amount on 2021-08-23 in Series A
Elixiron Immunotherapeutics is a company developing therapeutics for cancer, rare, and inflammatory disorders
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 23, 2021 |  Series A - Elixiron Immunotherapeutics | 6 | - | undefined |
| Jul 12, 2022 | Grant - Elixiron Immunotherapeutics | 1 | - | undefined |
| Mar 28, 2024 | Funding Round - Elixiron Immunotherapeutics | - | 13.8M | |
| Aug 26, 2020 | Grant - Elixiron Immunotherapeutics | 2 | - | 1.0M |
Recent Activity
There is no recent news or activity for this profile.